The hydrolysis of Striatal adenine- and guanine-based purines in a 6-hydroxydopamine rat model of Parkinson's disease

Neurochemical Research

Volumn 36, Issue 2, 2011, Pages 215-222

  Oses, Jean Pierre ^a,d   Batassini, Cristiane ^a   Pochmann, Daniela ^a   Böhmer, Ana Elisa ^a   Vuaden, Fernanda Cenci ^a   Silvestrin, Roberta Bristot ^a   Oliveira, Alcyr ^b   Bonan, Carla Denise ^c   Bogo, Maurício Reis ^c   Souza, Diogo Onofre ^a   Portela, Luis Valmor Cruz ^a   De Freitas Sarkis, João José ^a   E Souza, Tadeu Mello ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

5 nucleotidase; 6 OHDA; Adenosine; Guanosine; NTPDases; Parkinson's

Indexed keywords

5' NUCLEOTIDASE; ADENINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; DOPAMINE; GUANINE; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATE; NUCLEOSIDE TRIPHOSPHATE; OXIDOPAMINE; PURINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GENETIC TRANSCRIPTION; MALE; MEDIAL FOREBRAIN BUNDLE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN HYDROLYSIS; RAT;

5'-NUCLEOTIDASE; ACID ANHYDRIDE HYDROLASES; ADENINE; ADRENERGIC AGENTS; ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; GUANINE; ISOENZYMES; MALE; MEDIAL FOREBRAIN BUNDLE; OXIDOPAMINE; PARKINSON DISEASE; PHOSPHATES; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 78751611199     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-010-0305-1     Document Type: Article

References (57)

1. R Deumens A Blokland J Prickaerts 2002 Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway Exp Neurol 175 2 303 317 1:CAS:528:DC%2BD38XksVequr0%3D 10.1006/exnr.2002.7891 12061862 (Pubitemid 34634286)
2. F Hefti E Melamed RJ Wurtman 1980 Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization Brain Res 195 1 123 137 1:CAS:528:DyaL3cXlt1Kgt78%3D 10.1016/0006-8993(80)90871-9 6105003 (Pubitemid 10077835)
3. H Yuan S Sarre G Ebinger, et al. 2005 Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease J Neurosci Methods 144 1 35 45 10.1016/j.jneumeth.2004.10.004 15848237 (Pubitemid 40546300)
4. A Pinna C Corsi AR Carta, et al. 2002 Modification of adenosine extracellular levels and adenosine A(2A) receptor mRNA by dopamine denervation Eur J Pharmacol 446 1-3 75 82 1:CAS:528:DC%2BD38XkvFGru78%3D 10.1016/S0014-2999(02)01818-6 12098587 (Pubitemid 34722559)
5. DA Loeffler PA LeWitt PL Juneau, et al. 1998 Altered guanosine and guanine concentrations in rabbit striatum following increased dopamine turnover Brain Res Bull 45 3 297 299 1:CAS:528:DyaK1cXitlOqs7s%3D 10.1016/S0361-9230(97) 00367-5 9510422 (Pubitemid 28113012)
6. Y Yang X Liu Y Long, et al. 2005 Systematic administration of iptakalim, an ATP-sensitive potassium channel opener, prevents rotenone-induced motor and neurochemical alterations in rats J Neurosci Res 80 3 442 449 1:CAS:528:DC%2BD2MXjvFakt7o%3D 10.1002/jnr.20467 15795934 (Pubitemid 40780833)
7. Y Yang X Liu Y Long, et al. 2006 Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats Int J Neuropsychopharmacol 9 1 51 61 1:CAS:528:DC%2BD28Xht1eiuw%3D%3D 10.1017/S1461145705005547 15927086 (Pubitemid 43068334)
8. J Alcayaga M Retamal V Cerpa, et al. 2003 Dopamine inhibits ATP-induced responses in the cat petrosal ganglion in vitro Brain Res 966 2 283 287 1:CAS:528:DC%2BD3sXhs1agsLw%3D 10.1016/S0006-8993(02)04215-4 12618351 (Pubitemid 36255591)
9. EA Newman 2003 Glial cell inhibition of neurons by release of ATP J Neurosci 23 5 1659 1666 1:CAS:528:DC%2BD3sXjtFyltLs%3D 12629170
10. M Sorimachi K Yamagami M Wakomori 2002 Activation of ATP receptor increases the cytosolic Ca(2+) concentration in ventral tegmental area neurons of rat brain Brain Res 935 1-2 129 133 1:CAS:528:DC%2BD38XivF2rtLo%3D 10.1016/S0006-8993(02)02473-3 12062483 (Pubitemid 34327855)
11. DL de Oliveira JF Horn JM Rodrigues, et al. 2004 Quinolinic acid promotes seizures and decreases glutamate uptake in young rats: reversal by orally administered guanosine Brain Res 1018 1 48 54 10.1016/j.brainres.2004.05.033 15262204 (Pubitemid 38942860)
12. ME Frizzo FA Antunes Soares LP Dall'Onder, et al. 2003 Extracellular conversion of guanine-based purines to guanosine specifically enhances astrocyte glutamate uptake Brain Res 972 1-2 84 89 1:CAS:528:DC%2BD3sXjtVCqu7s%3D 12711081
13. ME Frizzo DR Lara S Prokopiuk Ade, et al. 2002 Guanosine enhances glutamate uptake in brain cortical slices at normal and excitotoxic conditions Cell Mol Neurobiol 22 3 353 363 1:CAS:528:DC%2BD38XnvFOhsr0%3D 10.1023/A:1020728203682 12469876 (Pubitemid 35364892)
14. JX Jiang K Mikami VH Shah, et al. 2008 Leptin induces phagocytosis of apoptotic bodies by hepatic stellate cells via a Rho guanosine triphosphatase-dependent mechanism Hepatology 48 5 1497 1505 1:CAS:528:DC%2BD1cXhsVKmtrfK 10.1002/hep.22515 18925608
15. S Jiang P Ballerini S Buccella, et al. 2008 Remyelination after chronic spinal cord injury is associated with proliferation of endogenous adult progenitor cells after systemic administration of guanosine Purinergic Signal 4 1 61 71 1:CAS:528:DC%2BD1cXkt1Wrtb4%3D 10.1007/s11302-007-9093-8 18368534
16. S Jiang F Bendjelloul P Ballerini, et al. 2007 Guanosine reduces apoptosis and inflammation associated with restoration of function in rats with acute spinal cord injury Purinergic Signal 3 4 411 421 1:CAS:528: DC%2BD2sXhsVWju7vL 10.1007/s11302-007-9079-6 18404454
17. S Jiang G Fischione P Giuliani, et al. 2008 Metabolism and distribution of guanosine given intraperitoneally: implications for spinal cord injury Nucleosides Nucleotides Nucleic Acids 27 6 673 680 1:CAS:528: DC%2BD1cXotFels7g%3D 10.1080/15257770802143962 18600525 (Pubitemid 351948543)
18. S Jiang MI Khan Y Lu, et al. 2003 Guanosine promotes myelination and functional recovery in chronic spinal injury Neuroreport 14 18 2463 2467 1:CAS:528:DC%2BD3sXps1agsro%3D 10.1097/00001756-200312190-00034 14663211
19. DR Lara AP Schmidt ME Frizzo, et al. 2001 Effect of orally administered guanosine on seizures and death induced by glutamatergic agents Brain Res 912 2 176 180 1:CAS:528:DC%2BD3MXmsFahsLc%3D 10.1016/S0006-8993(01)02734-2 11532434 (Pubitemid 32800672)
20. S Molz H Decker IJ Oliveira, et al. 2005 Neurotoxicity induced by glutamate in glucose-deprived rat hippocampal slices is prevented by GMP Neurochem Res 30 1 83 89 1:CAS:528:DC%2BD2MXotV2nsg%3D%3D 10.1007/s11064-004- 9689-0 15756936 (Pubitemid 40254208)
21. SP Oleskovicz WC Martins RB Leal, et al. 2008 Mechanism of guanosine-induced neuroprotection in rat hippocampal slices submitted to oxygen-glucose deprivation Neurochem Int 52 3 411 418 1:CAS:528: DC%2BD1cXosV2rsw%3D%3D 10.1016/j.neuint.2007.07.017 17822807
22. AP Schmidt DR Lara DO Souza 2007 Proposal of a guanine-based purinergic system in the mammalian central nervous system Pharmacol Ther 116 3 401 416 1:CAS:528:DC%2BD2sXhtlCrs7bO 10.1016/j.pharmthera.2007.07.004 17884172 (Pubitemid 350116938)
23. FA Soares AP Schmidt M Farina, et al. 2004 Anticonvulsant effect of GMP depends on its conversion to guanosine Brain Res 1005 1-2 182 186 1:CAS:528:DC%2BD2cXisVGns78%3D 10.1016/j.brainres.2004.01.053 15044076 (Pubitemid 38388411)
24. C Su N Elfeki P Ballerini, et al. 2009 Guanosine improves motor behavior, reduces apoptosis, and stimulates neurogenesis in rats with parkinsonism J Neurosci Res 87 3 617 625 1:CAS:528:DC%2BD1MXit1Wiu7w%3D 10.1002/jnr.21883 18816792
25. AP Thomazi B Boff TD Pires, et al. 2008 Profile of glutamate uptake and cellular viability in hippocampal slices exposed to oxygen and glucose deprivation: developmental aspects and protection by guanosine Brain Res 1188 233 240 1:CAS:528:DC%2BD2sXhsVOktrjM 10.1016/j.brainres.2007.10.037 18053975 (Pubitemid 350296059)
26. Souza TM, Batassini C, Ribeiro L et al (2010) Effect of guanosine and epicatechin on the footfault testing-induced rotational behavior in parkinsonian rats lesioned with 6-hydroxydopamine; Program No. 558.15 Neuroscience Meeting Planner. Society for Neuroscience, San Diego, CA
27. Battastini AM, da Rocha JB, Barcellos CK et al (1991) Characterization of an ATP diphosphohydrolase (EC 3.6.1.5) in synaptosomes from cerebral cortex of adult rats. Neurochem Res 16(12):1303-1310
28. LV Cruz Portela JP Oses AL Silveira, et al. 2002 Guanine and adenine nucleotidase activities in rat cerebrospinal fluid Brain Res 950 1-2 74 78 10.1016/S0006-8993(02)02987-6 12231230 (Pubitemid 35253917)
29. F Kukulski SA Levesque EG Lavoie, et al. 2005 Comparative hydrolysis of P2 receptor agonists by NTPDases1, 2, 3 and 8 Purinergic Signal 1 2 193 204 1:CAS:528:DC%2BD2MXkslOgsbk%3D 10.1007/s11302-005-6217-x 18404504 (Pubitemid 40475234)
30. H Zimmermann 2001 Ectonucleotidases: some recent developments and a note on nomenclature Drug Dev Res 52 44 56 1:CAS:528:DC%2BD3MXjsVajs7Y%3D 10.1002/ddr.1097 (Pubitemid 32401923)
31. KM Chan D Delfert KD Junger 1986 A direct colorimetric assay for Ca2+ -stimulated ATPase activity Anal Biochem 157 2 375 380 1:CAS:528: DyaL28XlvVKgtL0%3D 10.1016/0003-2697(86)90640-8 2946250
32. P Cognato Gde AN Bruno RS da Silva, et al. 2007 Antiepileptic drugs prevent changes induced by pilocarpine model of epilepsy in brain ecto-nucleotidases Neurochem Res 32 6 1046 1055 10.1007/s11064-006-9272-y 17401672 (Pubitemid 46726026)
33. MM Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248 254 1:CAS:528:DyaE28XksVehtrY%3D 10.1016/0003-2697(76)90527- 3 942051
34. G Burnstock 2004 Cotransmission Curr Opin Pharmacol 4 1 47 52 1:CAS:528:DC%2BD2cXpsVGjtw%3D%3D 10.1016/j.coph.2003.08.001 15018838 (Pubitemid 38145837)
35. RA Cunha 2001 Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals Neurochem Res 26 8-9 979 991 1:CAS:528: DC%2BD3MXnvF2it70%3D 10.1023/A:1012392719601 11699950 (Pubitemid 33021424)
36. S Latini M Pazzagli G Pepeu, et al. 1996 A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system Gen Pharmacol 27 6 925 933 1:CAS:528:DyaK28XmtFentLY%3D 8909972 (Pubitemid 26345044)
37. P Svenningsson C Le Moine G Fisone, et al. 1999 Distribution, biochemistry and function of striatal adenosine A2A receptors Prog Neurobiol 59 4 355 396 1:CAS:528:DyaK1MXmtlCgsbo%3D 10.1016/S0301-0082(99)00011-8 10501634 (Pubitemid 29352341)
38. K Yabuuchi M Kuroiwa T Shuto, et al. 2006 Role of adenosine A1 receptors in the modulation of dopamine D1 and adenosine A2A receptor signaling in the neostriatum Neuroscience 141 1 19 25 1:CAS:528:DC%2BD28Xms1emtLk%3D 10.1016/j.neuroscience.2006.04.047 16750892
39. BB Fredholm 2003 Adenosine receptors as targets for drug development Drug News Perspect 16 5 283 289 1:CAS:528:DC%2BD3sXot1Cgt74%3D 10.1358/dnp.2003.16. 5.829316 12942159 (Pubitemid 37176216)
40. K Fuxe I Stromberg P Popoli, et al. 2001 Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum Adv Neurol 86 345 353 1:CAS:528: DC%2BD3MXjvFKhs7o%3D 11553995
41. M Ballarin M Herrera-Marschitz M Casas, et al. 1987 Striatal adenosine levels measured 'in vivo' by microdialysis in rats with unilateral dopamine denervation Neurosci Lett 83 3 338 344 1:CAS:528:DyaL1cXjt1Gktg%3D%3D 10.1016/0304-3940(87)90111-X 2450316 (Pubitemid 18001475)
42. RA Cunha P Brendel H Zimmermann, et al. 2000 Immunologically distinct isoforms of ecto-5′-nucleotidase in nerve terminals of different areas of the rat hippocampus J Neurochem 74 1 334 338 1:CAS:528:DC%2BD3cXltlSm 10.1046/j.1471-4159.2000.0740334.x 10617137 (Pubitemid 30012786)
43. S James PJ Richardson 1993 Production of adenosine from extracellular ATP at the striatal cholinergic synapse J Neurochem 60 1 219 227 1:CAS:528:DyaK3sXnsVWktA%3D%3D 10.1111/j.1471-4159.1993.tb05841.x 8417143 (Pubitemid 23006721)
44. Naito Y, Lowenstein JM (1985) 5′-Nucleotidase from rat heart membranes. Inhibition by adenine nucleotides and related compounds. Biochem J 226(3):645-651
45. A Wieraszko G Goldsmith TN Seyfried 1989 Stimulation-dependent release of adenosine triphosphate from hippocampal slices Brain Res 485 2 244 250 1:CAS:528:DyaL1MXit12hs7Y%3D 10.1016/0006-8993(89)90567-2 2566360 (Pubitemid 19102823)
46. P Correia-de-Sa MA Timoteo JA Ribeiro 1996 Presynaptic A1 inhibitory/A2A facilitatory adenosine receptor activation balance depends on motor nerve stimulation paradigm at the rat hemidiaphragm J Neurophysiol 76 6 3910 3919 1:CAS:528:DyaK2sXpt1ajsg%3D%3D 8985888
47. RA Cunha 2001 Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors Neurochem Int 38 2 107 125 1:CAS:528:DC%2BD3MXotVartw%3D%3D 10.1016/S0197-0186(00)00034-6 11137880 (Pubitemid 32014381)
48. RA Cunha P Correia-de-Sa AM Sebastiao, et al. 1996 Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides Br J Pharmacol 119 2 253 260 1:CAS:528:DyaK28XmtFSisrY%3D 8886406
49. JK Ryu J Kim SH Choi, et al. 2002 ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors Neuroreport 13 13 1611 1615 1:CAS:528:DC%2BD38XnsVaku7s%3D 10.1097/00001756-200209160-00008 12352612
50. D Marcellino D Suarez-Boomgaard MD Sanchez-Reina, et al. 2010 On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson's disease: studies with the P2X(7) receptor antagonist A-438079 J Neural Transm 117 6 681 687 1:CAS:528:DC%2BC3cXmslOgtro%3D 10.1007/s00702-010- 0400-0 20387084
51. EA Mazzio RR Reams KF Soliman 2004 The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro Brain Res 1004 1-2 29 44 1:CAS:528: DC%2BD2cXitFaqt7s%3D 10.1016/j.brainres.2003.12.034 15033417 (Pubitemid 38368060)
52. MA Tirmenstein CX Hu MS Scicchitano, et al. 2005 Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells Toxicol In Vitro 19 4 471 479 1:CAS:528: DC%2BD2MXjtF2jsL0%3D 10.1016/j.tiv.2005.01.006 15826805
53. DW Busija Z Lacza N Rajapakse, et al. 2004 Targeting mitochondrial ATP-sensitive potassium channels-a novel approach to neuroprotection Brain Res Brain Res Rev 46 3 282 294 1:CAS:528:DC%2BD2cXhtVantL3F 10.1016/j.brainresrev. 2004.06.011 15571770 (Pubitemid 39574329)
54. Fuxe K, Manger P, Genedani S et al (2006) The nigrostriatal DA pathway and Parkinson's disease. J Neural Transm Suppl 70:71-83
55. RB de Oliveira F Klamt MA Castro, et al. 2005 Morphological and oxidative alterations on Sertoli cells cytoskeleton due to retinol-induced reactive oxygen species Mol Cell Biochem 271 1-2 189 196 1:CAS:528:DC%2BD2MXivFelsr8%3D 10.1007/s11010-005-6339-z 15881670 (Pubitemid 40528477)
56. DA Loeffler DM Camp PL Juneau, et al. 2000 Purine-induced alterations of dopamine metabolism in rat pheochromocytoma PC12 cells Brain Res Bull 52 6 553 558 1:CAS:528:DC%2BD3cXmt1ajs74%3D 10.1016/S0361-9230(00)00293-8 10974496
57. SC Robson J Sevigny H Zimmermann 2006 The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance Purinergic Signal 2 2 409 430 1:CAS:528:DC%2BD28XhtVKns7fN 10.1007/s11302-006-9003-5 18404480